What is Agilysys' operating income?

Agilysys' total operating income in 2026 was $43.02 million, based on the following breakdown: Total Gross Profit: $199.92 million Total Operating Expenses: $156.91 million

Agilysys (AGYS) Financials

$88.52 -0.90 (-1.01%)

Closing price 06/5/2026 04:00 PM Eastern

Extended Trading

$88.50 -0.02 (-0.02%)

As of 06/5/2026 04:20 PM Eastern

Compare

Annual Income Statements for Agilysys

This table shows Agilysys' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	3/31/2016	3/31/2017	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024	3/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	-3.77	-12	-8.05	-13	-34	-24	4.64	13	85	23	39
Consolidated Net Income / (Loss)	-3.77	-12	-8.35	-13	-34	-21	6.48	15	86	23	39
Net Income / (Loss) Continuing Operations	-3.77	-12	-8.05	-13	-34	-21	6.48	15	86	23	39
Total Pre-Tax Income	-3.76	-11	-12	-13	-34	-21	6.51	16	21	26	48
Total Operating Income	-4.31	-11	-12	-13	-34	-21	6.32	13	16	23	43
Total Gross Profit	68	64	64	74	81	89	102	121	144	172	200
Total Revenue	120	128	127	141	161	137	163	198	237	276	319
Operating Revenue	120	128	127	141	161	137	163	198	237	276	319
Total Cost of Revenue	52	64	63	67	80	48	61	77	93	104	119
Operating Cost of Revenue	52	64	63	67	80	48	61	77	93	104	119
Total Operating Expenses	72	75	76	87	115	110	95	108	129	149	157
Selling, General & Admin Expense	22	20	24	23	24	36	29	31	36	41	42
Marketing Expense	20	21	18	20	20	14	15	23	28	33	40
Research & Development Expense	27	29	28	38	41	55	46	50	57	62	73
Depreciation Expense	2.20	2.41	2.63	2.50	2.57	2.83	2.21	1.77	3.90	3.68	3.84
Amortization Expense	1.24	1.39	1.88	2.57	2.54	1.96	1.65	1.74	1.37	3.86	5.75
Other Operating Expenses / (Income)	-	-	-	1.17	0.58	-	-	0.44	1.76	4.63	-7.68
Other Special Charges / (Income)	0.45	0.09	0.15	0.14	-0.13	0.20	0.97	0.35	0.03	0.84	0.27
Total Other Income / (Expense), net	0.55	-0.08	0.48	0.14	0.20	-0.25	0.19	2.89	4.93	3.04	5.39
Interest Expense	0.03	0.02	0.01	0.01	0.01	0.02	0.01	0.00	0.00	1.53	0.49
Interest & Investment Income	0.09	0.16	0.10	0.34	0.38	0.11	0.06	2.19	5.08	3.78	1.99
Other Income / (Expense), net	0.49	-0.22	0.39	-0.19	-0.18	-0.34	0.15	0.70	-0.15	0.79	3.89
Income Tax Expense	0.01	0.24	-3.25	0.22	0.20	-0.21	0.03	1.18	-66	2.41	9.62
Preferred Stock Dividends Declared	-	-	-	0.00	0.00	2.61	1.84	1.84	1.20	0.00	0.00
Basic Earnings per Share	($0.17)	($0.52)	($0.37)	($0.57)	($1.47)	($1.01)	$0.19	$0.52	$3.31	$0.84	$1.39
Weighted Average Basic Shares Outstanding	22.48M	22.62M	22.80M	23.04M	23.23M	23.46M	24.36M	24.69M	25.67M	27.52M	27.92M
Diluted Earnings per Share	($0.17)	($0.52)	($0.37)	($0.57)	($1.47)	($1.01)	$0.18	$0.49	$3.17	$0.82	$1.37
Weighted Average Diluted Shares Outstanding	22.48M	22.62M	22.80M	23.04M	23.23M	23.46M	25.48M	25.93M	26.84M	28.26M	28.39M
Weighted Average Basic & Diluted Shares Outstanding	22.48M	22.62M	22.80M	23.04M	23.40M	23.89M	24.74M	25.34M	27.45M	28.02M	28.17M

This table shows Agilysys' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	4.09	77	66	14	1.36	3.83	-	4.89	12	9.90	12
Consolidated Net Income / (Loss)	4.55	77	67	14	1.36	3.83	-	4.89	12	9.90	12
Net Income / (Loss) Continuing Operations	4.55	77	67	14	1.36	3.83	-	4.89	12	9.90	12
Total Pre-Tax Income	4.84	9.10	0.42	7.37	5.15	7.74	-	4.85	16	13	15
Total Operating Income	3.56	7.75	-1.53	5.75	4.13	7.41	-	4.52	14	12	13
Total Gross Profit	35	38	17	40	43	44	-	47	49	50	53
Total Revenue	59	61	36	64	68	70	-	77	79	80	83
Operating Revenue	59	61	36	64	68	70	-	77	79	80	83
Total Cost of Revenue	24	23	19	24	25	26	-	29	30	30	30
Operating Cost of Revenue	24	23	19	24	25	26	-	29	30	30	30
Total Operating Expenses	32	30	19	34	39	36	-	43	35	39	41
Selling, General & Admin Expense	9.00	9.06	3.51	10	10	9.54	-	11	10	11	10
Marketing Expense	6.40	6.14	3.62	7.01	8.79	9.01	-	12	9.78	9.11	9.10
Research & Development Expense	15	15	11	15	16	15	-	17	18	19	19
Depreciation Expense	1.21	0.91	1.16	0.84	0.92	0.99	-	0.94	0.96	1.01	0.92
Amortization Expense	0.35	0.34	-1.41	0.25	0.90	1.62	-	1.46	1.43	1.42	1.44
Other Operating Expenses / (Income)	-	-0.92	-	0.55	2.04	-0.01	-	0.26	-5.46	-2.72	0.23
Other Special Charges / (Income)	-	0.00	-0.67	0.27	0.10	0.33	-	0.11	0.11	-0.06	0.11
Total Other Income / (Expense), net	1.28	1.35	1.95	1.63	1.02	0.33	-	0.33	1.56	1.15	2.35
Interest Expense	0.00	0.00	-1.12	0.00	0.46	0.66	-	0.22	0.06	0.03	0.19
Interest & Investment Income	1.23	1.25	1.79	1.78	1.10	0.42	-	0.45	0.35	0.49	0.71
Other Income / (Expense), net	0.05	0.10	-0.95	-0.16	0.38	0.57	-	0.10	1.27	0.70	1.83
Income Tax Expense	0.30	-68	-66	-6.73	3.78	3.91	-	-0.04	4.00	2.99	2.67
Basic Earnings per Share	$0.16	$2.98	$2.60	$0.52	$0.05	$0.14	-	$0.18	$0.42	$0.35	$0.44
Weighted Average Basic Shares Outstanding	25.02M	25.81M	25.67M	27.13M	27.53M	27.67M	27.52M	27.79M	27.88M	27.97M	27.92M
Diluted Earnings per Share	$0.16	$2.85	$2.48	$0.50	$0.05	$0.14	-	$0.17	$0.41	$0.35	$0.44
Weighted Average Diluted Shares Outstanding	26.12M	26.98M	26.84M	28.13M	28.26M	28.31M	28.26M	28.29M	28.40M	28.44M	28.39M
Weighted Average Basic & Diluted Shares Outstanding	25.37M	27.36M	27.45M	27.88M	27.95M	27.96M	28.02M	28.04M	28.04M	28.11M	28.17M

This table details how cash moves in and out of Agilysys' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	3/31/2016	3/31/2017	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024	3/31/2025	3/31/2026
Net Change in Cash & Equivalents	-14	-11	-9.51	0.94	5.88	53	-2.21	16	32	-72	44
Net Cash From Operating Activities	7.22	3.43	6.87	7.24	11	28	28	34	48	55	70
Net Cash From Continuing Operating Activities	7.22	3.43	6.87	7.24	11	28	28	34	48	55	70
Net Income / (Loss) Continuing Operations	-3.77	-12	-8.35	-13	-34	-21	6.48	15	86	23	39
Consolidated Net Income / (Loss)	-3.77	-12	-8.35	-13	-34	-21	6.48	15	86	23	39
Depreciation Expense	2.20	2.41	2.63	2.50	2.57	2.83	2.21	1.77	3.90	3.68	3.84
Amortization Expense	2.27	9.40	12	15	15	1.96	1.65	1.90	1.53	4.32	6.41
Non-Cash Adjustments To Reconcile Net Income	3.73	2.17	4.69	4.39	29	40	15	13	13	18	22
Changes in Operating Assets and Liabilities, net	2.79	1.17	-3.99	-1.66	-1.97	4.48	3.39	3.19	-56	6.10	-0.87
Net Cash From Investing Activities	-21	-14	-15	-5.53	-3.45	-1.39	-26	-6.87	-7.60	-149	-1.85
Net Cash From Continuing Investing Activities	-21	-14	-15	-5.53	-3.45	-1.39	-26	-6.87	-7.60	-149	-1.85
Purchase of Property, Plant & Equipment	-5.90	-4.16	-6.14	-	-3.42	-1.39	-1.20	-7.24	-8.13	-2.78	-1.85
Acquisitions	-	0.00	-	-	0.00	0.00	-24	0.40	0.00	-146	0.00
Sale of Property, Plant & Equipment	-	-	-	3.32	-	-	0.00	0.00	0.55	0.00	0.00
Other Investing Activities, net	-15	-9.71	-8.95	2.22	-0.03	-0.00	-0.03	-0.03	-0.03	-0.03	0.00
Net Cash From Financing Activities	-0.58	-0.45	-1.30	-0.77	-1.12	25	-4.90	-11	-8.56	22	-24
Net Cash From Continuing Financing Activities	-0.58	-0.85	-1.30	-0.77	-1.12	25	-4.90	-11	-8.56	22	-24
Repayment of Debt	-0.14	-0.12	-0.12	-0.12	-0.02	-0.02	-0.02	-0.00	-0.00	-26	-24
Payment of Dividends	-	-	-	0.00	0.00	-1.12	-1.84	-1.84	-1.66	0.00	0.00
Issuance of Debt	-	-	-	-	-	-	-	0.00	0.00	50	0.00
Issuance of Common Equity	-	-	-	-	-	-	-	0.00	0.00	1.03	1.48
Other Financing Activities, net	-0.44	-0.73	-1.17	-0.65	-1.09	-7.51	-3.05	-9.25	-6.89	-2.74	-1.94
Effect of Exchange Rate Changes	-0.09	-0.07	-	-	-0.13	0.20	-0.10	-	0.02	-0.34	0.17

This table details how cash moves in and out of Agilysys' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026
Period end date	9/30/2024	12/31/2024	3/31/2024	6/30/2024	9/30/2025	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	-89	5.87	116	-0.78	-13	5.87	12	-17	3.77	22	35
Net Cash From Operating Activities	6.59	20	20	1.10	9.77	20	27	-4.35	15	23	36
Net Cash From Continuing Operating Activities	6.59	20	20	1.10	9.77	20	27	-4.35	15	23	36
Net Income / (Loss) Continuing Operations	1.36	3.83	67	14	2.49	3.83	3.93	4.89	12	9.90	12
Consolidated Net Income / (Loss)	1.36	3.83	67	14	2.49	3.83	3.93	4.89	12	9.90	12
Depreciation Expense	0.91	0.99	1.16	0.84	1.07	0.99	0.94	0.94	0.96	1.01	0.92
Amortization Expense	0.90	1.62	-1.25	0.25	2.97	1.62	1.24	1.62	1.60	1.58	1.61
Non-Cash Adjustments To Reconcile Net Income	4.03	4.22	0.29	4.43	5.60	4.22	5.12	5.03	5.00	5.77	6.03
Changes in Operating Assets and Liabilities, net	-0.62	9.63	-47	-19	-2.37	9.63	16	-17	-4.06	5.04	15
Net Cash From Investing Activities	-146	-0.59	139	-0.87	0.02	-0.59	-1.51	-0.63	-0.22	-0.57	-0.42
Net Cash From Continuing Investing Activities	-146	-0.59	139	-0.87	0.02	-0.59	-1.51	-0.63	-0.22	-0.57	-0.42
Purchase of Property, Plant & Equipment	-0.65	-0.56	-6.05	-0.87	0.02	-0.56	-0.70	-0.63	-0.22	-0.57	-0.42
Net Cash From Financing Activities	50	-13	-44	-0.93	-23	-13	-13	-13	-11	-0.62	0.11
Net Cash From Continuing Financing Activities	50	-13	-44	-0.93	-23	-13	-13	-13	-11	-0.62	0.11
Issuance of Common Equity	-	-	-0.45	-	-	-	0.57	-	-	-	0.70
Other Financing Activities, net	-0.50	-1.42	-4.05	-0.93	0.18	-1.42	0.11	-0.92	0.18	-0.62	-0.59
Effect of Exchange Rate Changes	0.18	-0.40	0.33	-0.08	0.33	-0.40	-0.04	0.43	-0.18	0.01	-0.08

This table presents Agilysys' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	3/31/2016	3/31/2017	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024	3/31/2025	3/31/2026
Total Assets	185	167	157	164	155	190	214	243	350	434	482
Total Current Assets	96	74	64	79	93	133	136	155	189	124	184
Cash & Equivalents	61	49	40	41	47	99	97	113	145	73	117
Accounts Receivable	22	16	16	27	36	26	25	22	29	32	43
Inventories, net	2.69	2.21	2.00	2.04	3.89	1.18	6.94	9.77	4.59	5.17	7.53
Prepaid Expenses	10	6.46	5.59	6.27	4.87	4.80	5.42	7.42	7.73	9.26	12
Other Current Assets	-	-	0.00	2.92	2.13	2.36	1.67	2.24	2.29	4.52	4.44
Plant, Property, & Equipment, net	15	16	18	16	12	8.79	6.35	15	18	17	14
Total Noncurrent Assets	74	78	76	69	49	48	72	74	144	294	283
Goodwill	20	20	20	20	20	20	33	33	33	131	134
Intangible Assets	52	56	54	43	8.40	8.40	20	18	17	71	66
Noncurrent Deferred & Refundable Income Taxes	-	-	-	0.44	0.76	1.80	2.66	2.79	67	67	58
Other Noncurrent Operating Assets	3.05	2.63	2.48	5.68	20	18	16	20	26	26	25
Total Liabilities & Shareholders' Equity	185	167	157	164	155	190	214	243	350	434	482
Total Liabilities	62	54	49	63	83	110	117	134	114	168	155
Total Current Liabilities	54	46	45	58	69	61	71	79	89	111	125
Accounts Payable	7.76	8.70	8.40	4.72	13	6.35	9.77	9.42	9.42	12	12
Accrued Expenses	13	8.33	9.24	14	9.03	11	11	14	20	22	24
Other Current Liabilities	-	-	27	39	47	43	51	55	60	76	88
Total Noncurrent Liabilities	7.58	7.30	4.20	5.15	13	49	45	55	25	57	30
Long-Term Debt	-	-	-	-	-	-	-	-	0.00	24	0.00
Noncurrent Deferred & Payable Income Tax Liabilities	3.08	3.18	0.23	0.86	0.88	0.92	0.94	2.26	0.55	11	10
Other Noncurrent Operating Liabilities	4.29	4.00	3.91	4.26	12	48	44	53	24	22	19
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	123	114	108	101	72	80	97	109	236	266	327
Total Preferred & Common Equity	123	114	108	101	72	80	97	109	236	266	327
Total Common Equity	123	114	108	101	72	80	97	109	236	266	327
Common Stock	1.84	3.70	7.57	10	15	47	59	62	105	120	142
Retained Earnings	124	113	104	93	59	35	40	53	138	161	200
Treasury Stock	-2.60	-2.52	-2.49	-2.43	-2.40	-2.28	-2.06	-1.88	-1.79	-1.60	-1.55
Accumulated Other Comprehensive Income / (Loss)	-0.18	-0.20	-0.26	-0.26	0.20	0.04	-0.06	-4.03	-4.17	-13	-13

This table presents Agilysys' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	6/30/2023	9/30/2023	12/31/2023	6/30/2024	9/30/2024	12/31/2024	6/30/2025	9/30/2025	12/31/2025
Total Assets	255	347	251	255	347	356	442	444	426	426	475
Total Current Assets	153	184	149	153	184	187	109	131	109	118	170
Cash & Equivalents	107	116	107	107	116	144	55	61	56	59	81
Accounts Receivable	28	49	26	28	49	27	32	49	35	37	64
Inventories, net	7.49	6.77	8.45	7.49	6.77	5.30	6.45	6.36	6.62	7.71	7.79
Prepaid Expenses	7.47	9.39	6.03	7.47	9.39	6.52	11	11	7.47	10	13
Other Current Assets	3.28	1.97	2.28	3.28	1.97	3.52	4.54	4.02	3.81	4.05	3.42
Plant, Property, & Equipment, net	17	18	16	17	18	18	18	17	16	15	15
Total Noncurrent Assets	84	145	86	84	145	151	316	296	301	292	291
Goodwill	33	33	33	33	33	33	135	129	136	134	136
Intangible Assets	18	17	18	18	17	17	79	74	72	70	69
Noncurrent Deferred & Refundable Income Taxes	3.15	68	2.93	3.15	68	76	75	68	67	63	61
Other Noncurrent Operating Assets	31	27	32	31	27	26	26	26	26	26	26
Total Liabilities & Shareholders' Equity	255	347	251	255	347	356	442	444	426	426	475
Total Liabilities	139	116	140	139	116	102	182	187	143	129	162
Total Current Liabilities	73	91	74	73	91	77	96	115	98	97	130
Accounts Payable	10	9.01	11	10	9.01	10	13	12	14	13	13
Accrued Expenses	14	15	11	14	15	13	22	17	12	16	19
Other Current Liabilities	49	67	52	49	67	54	61	86	71	68	98
Total Noncurrent Liabilities	66	25	66	66	25	24	86	72	45	32	32
Long-Term Debt	-	-	-	-	-	-	50	38	12	0.00	0.00
Noncurrent Deferred & Payable Income Tax Liabilities	2.28	1.04	2.30	2.28	1.04	0.55	12	12	12	11	12
Other Noncurrent Operating Liabilities	64	24	63	64	24	24	24	23	22	21	21
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	117	230	112	117	230	254	260	257	283	297	313
Total Preferred & Common Equity	117	230	112	117	230	254	260	257	283	297	313
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	117	230	112	117	230	254	260	257	283	297	313
Common Stock	65	101	63	65	101	108	112	115	125	131	136
Retained Earnings	58	135	54	58	135	152	153	157	166	178	187
Treasury Stock	-1.87	-1.80	-1.88	-1.87	-1.80	-1.64	-1.62	-1.62	-1.60	-1.59	-1.58
Accumulated Other Comprehensive Income / (Loss)	-4.09	-3.90	-3.51	-4.09	-3.90	-4.33	-3.62	-14	-6.06	-10	-8.50

This table displays calculated financial ratios and metrics derived from Agilysys' official financial filings.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	3/31/2016	3/31/2017	3/31/2018	3/31/2019	3/31/2020	3/31/2021	3/31/2022	3/31/2023	3/31/2024	3/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	28,108,247.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	28,108,247.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	1.38
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	16.28%	6.07%	-0.25%	10.59%	14.14%	-14.67%	18.56%	21.78%	19.89%	16.07%	15.85%
EBITDA Growth	111.40%	-71.81%	1,467.40%	55.13%	-476.30%	0.34%	162.58%	65.41%	22.12%	49.28%	82.15%
EBIT Growth	69.70%	-204.34%	-0.49%	-13.54%	-157.96%	37.80%	130.35%	109.96%	14.95%	49.88%	100.62%
NOPAT Growth	65.40%	-164.50%	-5.89%	-8.29%	-160.39%	38.47%	142.85%	89.43%	451.20%	-68.82%	68.41%
Net Income Growth	67.25%	-211.31%	28.76%	-57.65%	-158.79%	38.35%	130.85%	125.10%	491.11%	-73.06%	67.02%
EPS Growth	66.67%	-205.88%	28.85%	-54.05%	-157.89%	31.29%	117.82%	172.22%	546.94%	-74.13%	67.07%
Operating Cash Flow Growth	430.19%	-52.44%	100.23%	5.34%	46.04%	168.62%	0.24%	21.03%	39.82%	14.41%	26.97%
Free Cash Flow Firm Growth	30.78%	43.97%	-31.81%	96.97%	2,989.67%	172.64%	-144.99%	218.16%	-286.33%	-255.57%	139.52%
Invested Capital Growth	28.12%	2.33%	6.21%	-12.79%	-58.04%	-176.80%	101.94%	-1,041.87%	2,693.04%	136.77%	-3.20%
Revenue Q/Q Growth	2.75%	-1.03%	1.16%	-7.30%	13.16%	-2.37%	-4.91%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	118.84%	-90.51%	385.41%	-17.85%	-344.70%	19.79%	169.58%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	52.68%	-50.05%	21.89%	-13.76%	-216.16%	9.53%	138.28%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	45.81%	-40.10%	19.87%	-13.08%	-213.03%	9.37%	152.21%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	50.81%	-47.05%	37.81%	-34.53%	-219.46%	11.43%	140.18%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	-44.44%	36.21%	-29.55%	-219.57%	9.82%	122.78%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	33.39%	-70.74%	4,881.16%	11.49%	-2.04%	50.33%	-12.37%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	-79.30%	22.55%	22.39%	91.67%	141.50%	-40.12%	53.77%	0.00%	0.00%	0.00%	1,654.97%
Invested Capital Q/Q Growth	7.56%	-0.92%	-2.96%	-10.88%	-54.36%	-78.37%	-93.85%	0.00%	0.00%	0.00%	-9.40%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	56.58%	49.96%	50.58%	52.46%	50.36%	65.15%	62.43%	61.00%	60.75%	62.40%	62.61%
EBITDA Margin	0.53%	0.14%	2.23%	3.12%	-10.30%	-12.03%	6.35%	8.63%	8.79%	11.39%	17.90%
Operating Margin	-3.58%	-8.94%	-9.48%	-9.29%	-21.19%	-15.28%	3.89%	6.50%	6.63%	8.20%	13.47%
EBIT Margin	-3.18%	-9.11%	-9.18%	-9.42%	-21.30%	-15.52%	3.97%	6.85%	6.57%	8.48%	14.69%
Profit (Net Income) Margin	-3.13%	-9.18%	-6.56%	-9.35%	-21.19%	-15.31%	3.98%	7.36%	36.30%	8.43%	12.15%
Tax Burden Percent	100.16%	102.05%	71.98%	101.71%	100.59%	99.02%	99.49%	92.50%	416.72%	90.60%	80.13%
Interest Burden Percent	98.35%	98.74%	99.25%	97.52%	98.92%	99.59%	100.73%	116.15%	132.58%	109.64%	103.20%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.51%	7.50%	-316.72%	9.40%	19.87%
Return on Invested Capital (ROIC)	-5.37%	-12.49%	-12.69%	-14.25%	-56.09%	-503.19%	0.00%	0.00%	149.10%	13.27%	16.15%
ROIC Less NNEP Spread (ROIC-NNEP)	-4.26%	-5.66%	-12.92%	-4.29%	-32.68%	-494.51%	0.00%	0.00%	133.16%	10.43%	10.95%
Return on Net Nonoperating Assets (RNNOA)	2.33%	2.61%	5.17%	1.65%	16.56%	475.49%	0.00%	0.00%	-99.25%	-4.03%	-3.06%
Return on Equity (ROE)	-3.04%	-9.89%	-7.52%	-12.59%	-39.53%	-27.70%	7.31%	14.11%	49.85%	9.25%	13.09%
Cash Return on Invested Capital (CROIC)	-30.02%	-14.80%	-18.71%	-0.59%	25.68%	0.00%	-3,569.61%	0.00%	-32.18%	-67.95%	19.41%
Operating Return on Assets (OROA)	-2.08%	-6.60%	-7.20%	-8.27%	-21.52%	-12.37%	3.20%	5.94%	5.26%	5.96%	10.24%
Return on Assets (ROA)	-2.05%	-6.65%	-5.15%	-8.21%	-21.42%	-12.19%	3.21%	6.38%	29.05%	5.92%	8.47%
Return on Common Equity (ROCE)	-3.04%	-9.89%	-7.52%	-12.59%	-39.53%	-27.70%	7.31%	14.11%	49.85%	9.25%	13.09%
Return on Equity Simple (ROE_SIMPLE)	-3.05%	-10.31%	-7.70%	-13.08%	-47.48%	-26.29%	6.65%	13.34%	36.45%	8.73%	0.00%
Net Operating Profit after Tax (NOPAT)	-3.02	-7.99	-8.46	-9.16	-24	-15	6.29	12	66	20	34
NOPAT Margin	-2.51%	-6.25%	-6.64%	-6.50%	-14.83%	-10.69%	3.87%	6.01%	27.64%	7.43%	10.79%
Net Nonoperating Expense Percent (NNEP)	-1.10%	-6.83%	0.24%	-9.96%	-23.41%	-8.68%	0.19%	2.55%	15.95%	2.84%	5.21%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	7.06%	10.55%
Cost of Revenue to Revenue	43.42%	50.04%	49.42%	47.54%	49.64%	34.85%	37.57%	39.00%	39.25%	37.60%	37.39%
SG&A Expenses to Revenue	18.13%	15.57%	18.87%	16.41%	15.16%	26.10%	18.03%	15.70%	16.02%	14.81%	13.22%
R&D to Revenue	22.17%	22.75%	21.93%	26.85%	25.79%	40.35%	28.49%	25.38%	23.89%	22.64%	22.78%
Operating Expenses to Revenue	60.17%	58.89%	59.83%	61.74%	71.54%	80.43%	58.54%	54.50%	54.11%	54.20%	49.14%
Earnings before Interest and Taxes (EBIT)	-3.82	-12	-12	-13	-34	-21	6.46	14	16	23	47
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	0.64	0.18	2.84	4.40	-17	-17	10	17	21	31	57
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.90	1.93	2.56	4.95	5.51	14.19	10.13	19.03	9.04	7.63	6.12
Price to Tangible Book Value (P/TBV)	4.50	5.70	7.91	13.11	9.03	21.86	22.19	35.54	11.45	31.48	15.80
Price to Revenue (P/Rev)	1.95	1.72	2.18	3.54	2.46	8.26	6.06	10.50	9.00	7.36	6.26
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	212.32	163.19	25.16	87.34	51.55
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.47%	0.61%	3.98%	1.14%	1.94%
Enterprise Value to Invested Capital (EV/IC)	2.76	2.64	3.47	7.64	13.87	0.00	2,369.70	0.00	21.76	9.13	8.97
Enterprise Value to Revenue (EV/Rev)	1.45	1.34	1.87	3.25	2.17	7.54	5.46	9.93	8.39	7.18	5.90
Enterprise Value to EBITDA (EV/EBITDA)	271.48	941.95	83.94	103.95	0.00	0.00	86.04	115.14	95.53	63.08	32.94
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	137.48	144.94	127.75	84.66	40.14
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	141.35	165.17	30.36	96.71	54.62
Enterprise Value to Operating Cash Flow (EV/OCF)	24.15	49.66	34.64	63.18	32.95	36.42	31.21	57.08	41.36	35.91	26.90
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	31.93	34.77	0.00	124.37	0.00	0.00	45.46
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.09	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.09	0.00
Financial Leverage	-0.55	-0.46	-0.40	-0.39	-0.51	-0.96	-1.11	-1.02	-0.75	-0.39	-0.28
Leverage Ratio	1.48	1.49	1.46	1.53	1.85	2.27	2.28	2.21	1.72	1.56	1.55
Compound Leverage Factor	1.46	1.47	1.45	1.50	1.83	2.26	2.30	2.57	2.28	1.71	1.59
Debt to Total Capital	0.27%	0.21%	0.16%	0.03%	0.03%	0.01%	0.00%	0.00%	0.00%	8.28%	0.00%
Short-Term Debt to Total Capital	0.10%	0.11%	0.11%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.17%	0.10%	0.05%	0.03%	0.03%	0.01%	0.00%	0.00%	0.00%	8.28%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	99.73%	99.79%	99.84%	99.97%	99.97%	99.99%	100.00%	100.00%	100.00%	91.72%	100.00%
Debt to EBITDA	0.52	1.31	0.06	0.01	0.00	0.00	0.00	0.00	0.00	0.76	0.00
Net Debt to EBITDA	-93.89	-270.82	-14.02	-9.26	2.82	6.01	-9.39	0.00	0.00	-1.56	0.00
Long-Term Debt to EBITDA	0.33	0.64	0.02	0.01	0.00	0.00	0.00	0.00	0.00	0.76	0.00
Debt to NOPAT	-0.11	-0.03	-0.02	0.00	0.00	0.00	0.00	0.00	0.00	1.17	0.00
Net Debt to NOPAT	19.96	6.14	4.70	4.45	1.96	6.76	-15.42	0.00	0.00	-2.40	0.00
Long-Term Debt to NOPAT	-0.07	-0.01	-0.01	0.00	0.00	0.00	0.00	0.00	0.00	1.17	0.00
Altman Z-Score	4.07	4.13	5.05	6.29	3.89	7.25	6.55	11.01	12.97	8.59	9.47
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.77	1.59	1.43	1.37	1.35	2.18	1.91	1.97	2.11	1.11	1.47
Quick Ratio	1.53	1.40	1.26	1.17	1.19	2.04	1.71	1.72	1.95	0.94	1.28
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-17	-9.46	-12	-0.38	11	30	-13	16	-29	-105	41
Operating Cash Flow to CapEx	122.34%	82.56%	111.95%	0.00%	309.21%	2,045.14%	2,378.86%	476.14%	636.12%	1,980.88%	3,787.72%
Free Cash Flow to Firm to Interest Expense	-582.24	-630.71	-1,247.00	-37.77	1,212.70	1,487.82	-1,115.50	0.00	0.00	-68.54	84.01
Operating Cash Flow to Interest Expense	248.90	228.87	687.40	724.10	1,175.00	1,420.35	2,372.92	0.00	0.00	36.05	141.98
Operating Cash Flow Less CapEx to Interest Expense	45.45	-48.33	73.40	1,055.90	795.00	1,350.90	2,273.17	0.00	0.00	34.23	138.23
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.66	0.72	0.78	0.88	1.01	0.80	0.81	0.87	0.80	0.70	0.70
Accounts Receivable Turnover	5.07	6.79	7.96	6.49	5.11	4.45	6.39	8.33	9.17	9.04	8.56
Inventory Turnover	31.36	26.06	29.90	33.12	26.91	18.88	15.06	9.24	12.98	21.23	18.80
Fixed Asset Turnover	8.86	8.17	7.60	8.45	11.45	13.05	21.49	18.93	14.61	15.91	20.82
Accounts Payable Turnover	4.29	7.76	7.36	10.21	8.81	4.84	7.58	8.05	9.89	9.50	9.62
Days Sales Outstanding (DSO)	72.02	53.77	45.84	56.22	71.37	81.95	57.12	43.82	39.82	40.37	42.64
Days Inventory Outstanding (DIO)	11.64	14.00	12.21	11.02	13.56	19.33	24.24	39.49	28.12	17.19	19.42
Days Payable Outstanding (DPO)	85.02	47.02	49.59	35.75	41.44	75.40	48.12	45.32	36.89	38.41	37.96
Cash Conversion Cycle (CCC)	-1.37	20.75	8.46	31.49	43.50	25.89	33.25	37.98	31.06	19.15	24.09
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	63	65	69	60	25	-19	0.38	-3.53	92	217	210
Invested Capital Turnover	2.14	2.00	1.91	2.19	3.78	47.05	-17.19	-125.48	5.39	1.79	1.50
Increase / (Decrease) in Invested Capital	14	1.48	4.01	-8.78	-35	-44	20	-3.91	95	125	-6.95
Enterprise Value (EV)	174	170	238	458	348	1,034	889	1,967	1,993	1,979	1,883
Market Capitalization	235	220	278	498	395	1,134	986	2,080	2,138	2,029	2,000
Book Value per Share	$5.37	$4.89	$4.65	$4.28	$3.03	$3.38	$3.94	$4.34	$9.21	$9.51	$11.63
Tangible Book Value per Share	$2.27	$1.66	$1.51	$1.61	$1.85	$2.19	$1.80	$2.32	$7.28	$2.30	$4.50
Total Capital	124	114	109	101	72	80	97	109	236	290	327
Total Debt	0.33	0.24	0.18	0.04	0.03	0.01	0.00	0.00	0.00	24	0.00
Total Long-Term Debt	0.22	0.12	0.06	0.04	0.03	0.01	0.00	0.00	0.00	24	0.00
Net Debt	-60	-49	-40	-41	-47	-99	-97	-113	-145	-49	-117
Capital Expenditures (CapEx)	5.90	4.16	6.14	-3.32	3.42	1.39	1.20	7.24	7.58	2.78	1.85
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-19	-22	-20	-20	-23	-27	-32	-37	-45	-61	-58
Debt-free Net Working Capital (DFNWC)	42	27	19	21	24	72	65	76	100	13	59
Net Working Capital (NWC)	41	27	19	21	24	72	65	76	100	13	59
Net Nonoperating Expense (NNE)	0.75	3.74	-0.11	4.01	10	6.33	-0.19	-2.67	-21	-2.76	-4.32
Net Nonoperating Obligations (NNO)	-60	-49	-40	-41	-47	-99	-97	-113	-145	-49	-117
Total Depreciation and Amortization (D&A)	4.46	12	15	18	18	4.79	3.86	3.51	5.26	8.00	10
Debt-free, Cash-free Net Working Capital to Revenue	-15.86%	-17.19%	-16.08%	-13.90%	-14.10%	-19.74%	-19.84%	-18.53%	-19.09%	-21.96%	-18.12%
Debt-free Net Working Capital to Revenue	34.49%	21.39%	15.28%	15.05%	14.92%	52.56%	39.79%	38.44%	41.93%	4.54%	18.48%
Net Working Capital to Revenue	34.40%	21.29%	15.19%	15.05%	14.92%	52.56%	39.79%	38.44%	41.93%	4.54%	18.48%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.17)	($0.52)	($0.37)	($0.57)	($1.47)	($1.01)	$0.19	$0.52	$3.31	$0.84	$1.39
Adjusted Weighted Average Basic Shares Outstanding	22.94M	23.21M	23.23M	23.50M	23.23M	23.46M	24.36M	24.69M	25.67M	27.52M	27.92M
Adjusted Diluted Earnings per Share	($0.17)	($0.52)	($0.37)	($0.57)	($1.47)	($1.01)	$0.18	$0.49	$3.17	$0.82	$1.37
Adjusted Weighted Average Diluted Shares Outstanding	22.94M	23.21M	23.23M	23.50M	23.40M	23.89M	25.48M	25.93M	26.84M	28.26M	28.39M
Adjusted Basic & Diluted Earnings per Share	($0.17)	($0.52)	($0.37)	($0.57)	($1.47)	($1.01)	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	22.48M	22.62M	22.80M	23.04M	23.40M	23.89M	24.74M	25.34M	27.45M	28.02M	28.17M
Normalized Net Operating Profit after Tax (NOPAT)	-2.51	-6.83	-7.09	-9.06	-7.31	-15	7.25	12	11	21	35
Normalized NOPAT Margin	-2.08%	-5.35%	-5.57%	-6.43%	-4.55%	-10.59%	4.46%	6.18%	4.65%	7.70%	10.86%
Pre Tax Income Margin	-3.12%	-9.00%	-9.11%	-9.19%	-21.07%	-15.46%	4.00%	7.96%	8.71%	9.30%	15.16%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-131.79	-775.47	-1,168.90	-1,327.20	-3,804.11	-1,064.80	538.67	0.00	0.00	15.29	95.15
NOPAT to Interest Expense	-104.11	-532.37	-845.60	-915.67	-2,649.19	-733.53	523.91	0.00	0.00	13.39	69.92
EBIT Less CapEx to Interest Expense	-335.24	-1,052.67	-1,782.90	-995.40	-4,184.11	-1,134.25	438.92	0.00	0.00	13.47	91.40
NOPAT Less CapEx to Interest Expense	-307.56	-809.57	-1,459.60	-583.87	-3,029.19	-802.98	424.16	0.00	0.00	11.57	66.17
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	-5.32%	28.34%	12.59%	1.93%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	-5.32%	28.34%	12.59%	1.93%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Agilysys' official financial filings.

Metric	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026
Period end date	9/30/2024	12/31/2024	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	27,963,988.00	-	28,042,795.00	28,042,508.00	28,108,247.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	27,963,988.00	-	28,042,795.00	28,042,508.00	28,108,247.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	0.00	-	0.42	0.35	0.44
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	16.49%	14.85%	58.22%	0.00%	0.00%	0.00%	0.00%	0.00%	16.14%	15.57%	11.68%
EBITDA Growth	22.40%	16.41%	-413.00%	0.00%	35.15%	0.00%	-52.56%	0.00%	184.21%	39.66%	126.78%
EBIT Growth	24.80%	1.76%	-288.89%	0.00%	0.00%	0.00%	-100.00%	0.00%	242.00%	55.66%	172.52%
NOPAT Growth	-67.30%	-94.42%	-57,328.15%	0.00%	0.00%	0.00%	-100.00%	0.00%	864.15%	145.90%	167.32%
Net Income Growth	-69.99%	-95.04%	197.44%	0.00%	0.00%	0.00%	0.00%	0.00%	758.50%	158.41%	213.22%
EPS Growth	-68.75%	-95.09%	196.88%	0.00%	0.00%	0.00%	0.00%	0.00%	720.00%	150.00%	238.46%
Operating Cash Flow Growth	20.96%	57.16%	25.65%	0.00%	48.24%	0.00%	-8.91%	0.00%	0.00%	14.82%	31.98%
Free Cash Flow Firm Growth	-5,500.64%	-420.78%	-7,885.09%	111.64%	107.78%	101.59%	-34.70%	103.65%	111.63%	109.78%	114.26%
Invested Capital Growth	2,674.30%	0.00%	2,693.04%	0.00%	-7.03%	0.00%	136.77%	0.00%	-7.03%	-1.01%	-3.20%
Revenue Q/Q Growth	7.51%	1.88%	-48.09%	75.88%	7.51%	1.88%	0.00%	0.00%	3.42%	1.38%	3.18%
EBITDA Q/Q Growth	-5.27%	67.41%	-124.32%	359.28%	28.03%	67.38%	-79.70%	0.00%	150.28%	-16.49%	12.97%
EBIT Q/Q Growth	-19.34%	77.07%	-131.09%	325.22%	-19.34%	77.07%	-100.00%	0.00%	233.86%	-19.41%	16.20%
NOPAT Q/Q Growth	-90.05%	235.15%	-6,701.41%	104.54%	-90.05%	235.15%	-100.00%	0.00%	131.27%	-14.52%	14.99%
Net Income Q/Q Growth	-90.33%	180.79%	1,646.61%	-78.91%	-90.33%	180.79%	0.00%	0.00%	139.47%	-15.48%	24.22%
EPS Q/Q Growth	-90.00%	180.00%	1,671.43%	-79.84%	-90.00%	180.00%	0.00%	0.00%	141.18%	-14.63%	25.71%
Operating Cash Flow Q/Q Growth	500.18%	207.86%	-0.38%	0.00%	789.71%	0.00%	33.83%	0.00%	450.05%	53.13%	53.83%
Free Cash Flow Firm Q/Q Growth	-159.42%	6.00%	-46.32%	103.26%	73.30%	235.15%	-7.71%	0.00%	122.80%	-60.11%	52.22%
Invested Capital Q/Q Growth	132.03%	-8.36%	-60.87%	20.17%	115.71%	-8.36%	-7.34%	0.00%	-0.94%	-2.42%	-9.40%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	63.29%	63.05%	47.96%	62.77%	63.29%	63.05%	0.00%	61.68%	61.75%	62.50%	64.40%
EBITDA Margin	9.27%	15.23%	-7.13%	10.52%	12.52%	15.23%	0.00%	9.37%	22.68%	18.68%	20.46%
Operating Margin	6.04%	10.65%	-4.24%	9.05%	6.04%	10.65%	0.00%	5.90%	17.84%	14.59%	15.21%
EBIT Margin	6.60%	11.48%	-6.87%	8.80%	6.60%	11.48%	0.00%	6.02%	19.45%	15.46%	17.41%
Profit (Net Income) Margin	2.00%	5.51%	185.24%	22.21%	2.00%	5.51%	0.00%	6.38%	14.77%	12.31%	14.82%
Tax Burden Percent	26.51%	49.46%	15,814.42%	191.35%	26.51%	49.46%	0.00%	100.85%	74.53%	76.82%	82.15%
Interest Burden Percent	114.13%	96.98%	-17.04%	131.88%	114.13%	96.98%	0.00%	104.98%	101.88%	103.66%	103.63%
Effective Tax Rate	73.49%	50.54%	-15,714.42%	-91.35%	73.49%	50.54%	0.00%	-0.85%	25.47%	23.18%	17.85%
Return on Invested Capital (ROIC)	2.61%	10.09%	-3,613.86%	39.43%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	18.70%
ROIC Less NNEP Spread (ROIC-NNEP)	2.12%	8.65%	-3,853.54%	37.27%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	16.37%
Return on Net Nonoperating Assets (RNNOA)	-0.63%	-0.77%	2,872.24%	-21.13%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-4.58%
Return on Equity (ROE)	1.97%	9.33%	-741.62%	18.30%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	14.11%
Cash Return on Invested Capital (CROIC)	-170.76%	-237.37%	-32.18%	-61.80%	0.00%	0.00%	-67.95%	0.00%	7.29%	1.01%	19.41%
Operating Return on Assets (OROA)	4.08%	5.80%	-5.50%	6.20%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	12.14%
Return on Assets (ROA)	1.23%	2.78%	148.24%	15.65%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	10.33%
Return on Common Equity (ROCE)	1.97%	9.33%	-741.62%	18.30%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	14.11%
Return on Equity Simple (ROE_SIMPLE)	9.21%	-19.22%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	1.09	3.67	-242	11	1.09	3.67	0.00	4.56	11	9.01	10
NOPAT Margin	1.60%	5.27%	-670.03%	17.31%	1.60%	5.27%	0.00%	5.95%	13.30%	11.21%	12.49%
Net Nonoperating Expense Percent (NNEP)	0.48%	1.45%	239.67%	2.16%	0.84%	0.72%	0.00%	0.76%	3.63%	1.70%	2.33%
Return On Investment Capital (ROIC_SIMPLE)	-	1.24%	-102.32%	4.33%	0.37%	1.24%	0.00%	1.54%	3.55%	2.88%	3.17%
Cost of Revenue to Revenue	36.71%	36.95%	52.04%	37.23%	36.71%	36.95%	0.00%	38.32%	38.25%	37.50%	35.60%
SG&A Expenses to Revenue	17.87%	13.71%	9.72%	16.51%	14.88%	13.71%	0.00%	14.03%	12.82%	13.48%	12.62%
R&D to Revenue	23.69%	21.52%	30.12%	23.18%	23.69%	21.52%	0.00%	22.76%	22.48%	23.54%	22.35%
Operating Expenses to Revenue	57.25%	52.39%	52.20%	53.72%	57.25%	52.39%	0.00%	55.78%	43.91%	47.90%	49.19%
Earnings before Interest and Taxes (EBIT)	4.51	7.98	-2.48	5.59	4.51	7.98	0.00	4.62	15	12	14
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	6.33	11	-2.58	6.68	8.55	11	2.18	7.19	18	15	17
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	11.67	14.34	9.04	11.25	10.24	14.34	7.63	11.34	9.95	10.64	6.12
Price to Tangible Book Value (P/TBV)	66.31	67.29	11.45	13.96	32.63	67.29	31.48	42.76	31.70	30.72	15.80
Price to Revenue (P/Rev)	14.12	16.42	9.00	11.41	0.00	0.00	7.36	0.00	0.00	0.00	6.26
Price to Earnings (P/E)	131.86	0.00	25.16	37.73	0.00	0.00	87.34	0.00	0.00	0.00	51.55
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.76%	0.00%	3.98%	2.65%	0.00%	0.00%	1.14%	0.00%	0.00%	0.00%	1.94%
Enterprise Value to Invested Capital (EV/IC)	11.88	15.63	21.76	24.67	12.55	15.63	9.13	13.22	12.18	14.03	8.97
Enterprise Value to Revenue (EV/Rev)	14.10	16.32	8.39	10.83	0.00	0.00	7.18	0.00	0.00	0.00	5.90
Enterprise Value to EBITDA (EV/EBITDA)	133.22	150.80	94.81	126.11	0.00	0.00	63.08	0.00	286.78	0.00	32.94
Enterprise Value to EBIT (EV/EBIT)	157.51	188.62	127.75	185.58	0.00	0.00	84.66	0.00	0.00	0.00	40.14
Enterprise Value to NOPAT (EV/NOPAT)	149.63	0.00	30.36	44.09	0.00	0.00	96.71	0.00	0.00	0.00	54.62
Enterprise Value to Operating Cash Flow (EV/OCF)	82.70	83.04	41.36	63.52	0.00	0.00	35.91	0.00	49.60	0.00	26.90
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	161.01	1,377.59	45.46
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.19	0.15	0.00	0.00	0.00	0.15	0.09	0.04	0.00	0.00	0.00
Long-Term Debt to Equity	0.19	0.15	0.00	0.00	0.00	0.15	0.09	0.04	0.00	0.00	0.00
Financial Leverage	-0.30	-0.09	-0.75	-0.57	-0.20	-0.09	-0.39	-0.16	-0.12	-0.18	-0.28
Leverage Ratio	1.85	1.73	1.72	1.40	1.43	1.73	1.56	1.45	1.56	1.61	1.55
Compound Leverage Factor	2.11	1.68	-0.29	1.85	1.64	1.68	0.00	1.53	1.59	1.67	1.60
Debt to Total Capital	16.12%	12.89%	0.00%	0.00%	0.00%	12.89%	8.28%	4.06%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	16.12%	12.89%	0.00%	0.00%	0.00%	12.89%	8.28%	4.06%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	83.88%	87.11%	100.00%	100.00%	100.00%	87.11%	91.72%	95.94%	100.00%	100.00%	100.00%
Debt to EBITDA	2.20	1.57	0.00	0.00	0.00	0.00	0.76	0.00	0.00	0.00	0.00
Net Debt to EBITDA	-0.21	-0.94	0.00	0.00	0.00	0.00	-1.56	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	2.20	1.57	0.00	0.00	0.00	0.00	0.76	0.00	0.00	0.00	0.00
Debt to NOPAT	2.47	-0.87	0.00	0.00	0.00	0.00	1.17	0.00	0.00	0.00	0.00
Net Debt to NOPAT	-0.24	0.52	0.00	0.00	0.00	0.00	-2.40	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	2.47	-0.87	0.00	0.00	0.00	0.00	1.17	0.00	0.00	0.00	0.00
Altman Z-Score	11.07	12.91	12.80	18.62	0.00	0.00	8.41	14.10	14.51	13.08	9.24
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.13	1.14	2.11	2.41	1.22	1.14	1.11	1.11	1.22	1.31	1.47
Quick Ratio	0.90	0.96	1.95	2.21	0.99	0.96	0.94	0.93	0.99	1.12	1.28
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-245	-230	-337	11	19	3.67	-125	4.56	29	11	17
Operating Cash Flow to CapEx	1,012.29%	3,609.96%	334.33%	0.00%	0.00%	3,609.96%	3,873.32%	-686.57%	7,010.60%	4,058.36%	8,451.65%
Free Cash Flow to Firm to Interest Expense	-535.10	-350.63	0.00	0.00	41.61	5.58	0.00	21.01	509.06	379.09	91.11
Operating Cash Flow to Interest Expense	14.39	30.88	0.00	0.00	21.33	30.88	0.00	-20.03	271.66	776.50	188.61
Operating Cash Flow Less CapEx to Interest Expense	12.97	30.02	0.00	0.00	21.37	30.02	0.00	-22.94	267.79	757.37	186.37
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.62	0.51	0.80	0.70	0.00	0.00	0.70	0.00	0.00	0.00	0.70
Accounts Receivable Turnover	7.25	4.55	9.17	9.18	0.00	0.00	9.04	0.00	0.00	0.00	8.56
Inventory Turnover	11.40	12.96	12.98	18.67	0.00	0.00	21.23	0.00	0.00	0.00	18.80
Fixed Asset Turnover	12.29	13.29	14.61	14.19	0.00	0.00	15.91	0.00	0.00	0.00	20.82
Accounts Payable Turnover	6.96	7.05	9.89	9.81	0.00	0.00	9.50	0.00	0.00	0.00	9.62
Days Sales Outstanding (DSO)	50.36	80.23	39.82	39.77	0.00	0.00	40.37	0.00	0.00	0.00	42.64
Days Inventory Outstanding (DIO)	32.01	28.17	28.12	19.55	0.00	0.00	17.19	0.00	0.00	0.00	19.42
Days Payable Outstanding (DPO)	52.42	51.76	36.89	37.20	0.00	0.00	38.41	0.00	0.00	0.00	37.96
Cash Conversion Cycle (CCC)	29.95	56.64	31.06	22.12	0.00	0.00	19.15	0.00	0.00	0.00	24.09
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	255	234	92	110	237	234	217	240	237	232	210
Invested Capital Turnover	1.63	1.92	5.39	2.28	0.00	0.00	1.79	0.00	0.00	0.00	1.50
Increase / (Decrease) in Invested Capital	246	234	95	0.00	-18	0.00	125	0.00	-18	-2.36	-6.95
Enterprise Value (EV)	3,033	3,659	1,993	2,715	2,979	3,659	1,979	3,168	2,892	3,251	1,883
Market Capitalization	3,038	3,681	2,138	2,859	3,038	3,681	2,029	3,212	2,952	3,333	2,000
Book Value per Share	$9.33	$9.19	$9.21	$9.26	$10.64	$9.19	$9.51	$10.11	$10.58	$11.17	$11.63
Tangible Book Value per Share	$1.64	$1.96	$7.28	$7.46	$3.34	$1.96	$2.30	$2.68	$3.32	$3.87	$4.50
Total Capital	310	295	236	254	297	295	290	295	297	313	327
Total Debt	50	38	0.00	0.00	0.00	38	24	12	0.00	0.00	0.00
Total Long-Term Debt	50	38	0.00	0.00	0.00	38	24	12	0.00	0.00	0.00
Net Debt	-4.89	-23	-145	-144	-59	-23	-49	-44	-59	-81	-117
Capital Expenditures (CapEx)	0.65	0.56	6.05	0.00	-0.02	0.56	0.70	0.63	0.22	0.57	0.42
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-42	-45	-45	-35	-38	-45	-61	-45	-38	-42	-58
Debt-free Net Working Capital (DFNWC)	13	16	100	109	21	16	13	11	21	40	59
Net Working Capital (NWC)	13	16	100	109	21	16	13	11	21	40	59
Net Nonoperating Expense (NNE)	-0.27	-0.16	-309	-3.11	-0.27	-0.16	0.00	-0.33	-1.17	-0.88	-1.93
Net Nonoperating Obligations (NNO)	-4.89	-23	-145	-144	-59	-23	-49	-44	-59	-81	-117
Total Depreciation and Amortization (D&A)	1.82	2.61	-0.09	1.09	4.04	2.61	2.18	2.57	2.56	2.59	2.53
Debt-free, Cash-free Net Working Capital to Revenue	-19.55%	-19.85%	-19.09%	-13.87%	0.00%	0.00%	-21.96%	0.00%	0.00%	0.00%	-18.12%
Debt-free Net Working Capital to Revenue	5.95%	7.25%	41.93%	43.64%	0.00%	0.00%	4.54%	0.00%	0.00%	0.00%	18.48%
Net Working Capital to Revenue	5.95%	7.25%	41.93%	43.64%	0.00%	0.00%	4.54%	0.00%	0.00%	0.00%	18.48%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.05	$0.14	$2.60	$0.52	$0.05	$0.14	$0.00	$0.18	$0.42	$0.35	$0.44
Adjusted Weighted Average Basic Shares Outstanding	27.53M	27.67M	25.67M	27.13M	27.53M	27.67M	27.52M	27.79M	27.88M	27.97M	27.92M
Adjusted Diluted Earnings per Share	$0.05	$0.14	$2.48	$0.50	$0.05	$0.14	$0.00	$0.17	$0.41	$0.35	$0.44
Adjusted Weighted Average Diluted Shares Outstanding	28.26M	28.31M	26.84M	28.13M	28.26M	28.31M	28.26M	28.29M	28.40M	28.44M	28.39M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	27.95M	27.96M	27.45M	27.88M	28.04M	27.96M	28.02M	28.04M	28.04M	28.11M	28.17M
Normalized Net Operating Profit after Tax (NOPAT)	2.96	5.42	-1.54	4.21	2.96	5.42	0.00	3.24	11	8.96	10
Normalized NOPAT Margin	4.34%	7.79%	-4.27%	6.63%	4.34%	7.79%	0.00%	4.23%	13.40%	11.15%	12.60%
Pre Tax Income Margin	7.54%	11.13%	1.17%	11.61%	7.54%	11.13%	0.00%	6.32%	19.81%	16.03%	18.04%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	9.85	12.15	0.00	0.00	9.85	12.15	0.00	21.29	275.38	414.27	76.01
NOPAT to Interest Expense	2.39	5.58	0.00	0.00	2.39	5.58	0.00	21.01	188.29	300.43	54.54
EBIT Less CapEx to Interest Expense	8.42	11.30	0.00	0.00	9.89	11.30	0.00	18.37	271.50	395.13	73.77
NOPAT Less CapEx to Interest Expense	0.97	4.72	0.00	0.00	2.43	4.72	0.00	18.09	184.42	281.29	52.31
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	3.83%	-0.35%	1.93%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	3.83%	-0.35%	1.93%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Financials Breakdown Chart

Key Financial Trends

Agilysys (NASDAQ: AGYS) has shown a strong turnaround over the last several years, with revenue growth, expanding profitability, and a much healthier balance sheet. The company’s latest quarter (Q4 FY2026) continued that trend, with revenue up year over year, solid operating leverage, and strong operating cash flow.

Revenue rose to $82.9 million in Q4 2026 from $80.4 million in the prior-year quarter, showing continued top-line growth.
Gross profit increased to $53.4 million, with gross margin improving to about 64.4% from roughly 62.5% a year earlier.
Operating income improved to $12.6 million in Q4 2026 versus $11.7 million in Q3 2026, while net income also ticked higher quarter over quarter.
Full-year momentum appears strong: quarterly net income in 2026 has remained consistently profitable, far better than the losses seen in earlier periods like 2022.
Operating cash flow was strong at $35.8 million in Q4 2026, suggesting the earnings growth is being backed by cash generation.
The company ended Q3 2026 with $81.5 million in cash and equivalents, up from $59.3 million at the end of Q2 2026, reinforcing liquidity.
Long-term debt was $0 in Q3 2026, indicating a very conservative capital structure at that point in the year.
Shareholders’ equity rose to $313.1 million in Q3 2026 from $283.2 million in Q1 2026, reflecting balance sheet improvement.

Revenue growth has been steady rather than explosive, with quarterly sales increasing modestly across the last few quarters.
The company continues to spend heavily on R&D and marketing, which supports growth but also keeps operating expenses elevated.
A large portion of assets remains tied up in goodwill and intangible assets, which is common after acquisitions but adds accounting risk if performance weakens.
Cash flow can be lumpy quarter to quarter because of working-capital swings, even though the overall trend has improved.

Accounts receivable jumped to $63.7 million in Q3 2026 from $35.1 million in Q1 2026, which could signal slower collections or strong end-of-quarter billing.
Current liabilities also increased meaningfully, reaching $129.9 million in Q3 2026, so near-term obligations remain sizable.
AOCI remained negative at -$8.5 million in Q3 2026, indicating some accumulated unrealized losses or foreign-currency/other comprehensive adjustments.
The company has a history of volatility in earlier years, including periods of net losses and uneven cash generation, so investors should watch whether the recent profitability is durable.

Bottom line: Agilysys appears to be in a much stronger fundamental position than it was a couple of years ago. Revenue is growing, margins are improving, cash flow is robust, and the balance sheet looks healthy. The main thing to watch now is whether the company can keep converting that growth into consistently higher earnings without letting receivables, expenses, or working capital erode cash quality.

06/07/26 10:34 PM ETAI Generated. May Contain Errors.

Agilysys Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Agilysys' fiscal year ends in March. Their fiscal year 2026 ended on March 31, 2026.

Agilysys' net income appears to be on an upward trend, with a most recent value of $38.79 million in 2026, falling from -$3.77 million in 2016. The previous period was $23.23 million in 2025. See where experts think Agilysys is headed by visiting Agilysys' forecast page.

Agilysys' total operating income in 2026 was $43.02 million, based on the following breakdown:

Total Gross Profit: $199.92 million
Total Operating Expenses: $156.91 million

Over the last 10 years, Agilysys' total revenue changed from $120.37 million in 2016 to $319.31 million in 2026, a change of 165.3%.

Agilysys' total liabilities were at $154.74 million at the end of 2026, a 8.2% decrease from 2025, and a 150.9% increase since 2016.

In the past 10 years, Agilysys' cash and equivalents has ranged from $39.94 million in 2018 to $144.89 million in 2024, and is currently $116.89 million as of their latest financial filing in 2026.

Over the last 10 years, Agilysys' book value per share changed from 5.37 in 2016 to 11.63 in 2026, a change of 116.3%.

Related Companies

Financial statements for NASDAQ:AGYS last updated on 5/23/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agilysys (AGYS) Financials

Financials Breakdown Chart

Key Financial Trends

Agilysys Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Agilysys (AGYS) Financials

Annual Income Statements for Agilysys

Quarterly Income Statements for Agilysys

Annual Cash Flow Statements for Agilysys

Quarterly Cash Flow Statements for Agilysys

Annual Balance Sheets for Agilysys

Quarterly Balance Sheets for Agilysys

Annual Metrics And Ratios for Agilysys

Quarterly Metrics And Ratios for Agilysys

Financials Breakdown Chart

Key Financial Trends

Agilysys Financials - Frequently Asked Questions

When does Agilysys' financial year end?

How has Agilysys' net income changed over the last 10 years?

What is Agilysys' operating income?

How has Agilysys' revenue changed over the last 10 years?

How much debt does Agilysys have?

How much cash does Agilysys have?

How has Agilysys' book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools